CJC‑1295 (without DAC) 10mg is a short-acting GHRH analogue for researchers who require tightly defined exposure windows in growth hormone axis experiments. Without the DAC modification, this peptide is suited to studying acute receptor engagement, rapid signalling events, and time‑resolved GH-related dynamics.

In vitro, it is frequently used in receptor-binding assays, comparative studies with longer-acting analogues, and investigations into peptide stability across different buffers and storage conditions. The 10mg vial size balances convenience for screening with sufficient material for extended series when handled carefully.

Each batch is produced to research-grade standards, with analytical data and COAs available on request to support confident experimental planning.

Disclaimer: For research use only. Not for human or animal consumption.